Purple Biotech (Israel) Probability of Future Stock Price Finishing Under 67.8

KTOV Stock  ILA 6.80  1.70  33.33%   
Purple Biotech's future price is the expected price of Purple Biotech instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Purple Biotech performance during a given time horizon utilizing its historical volatility. Check out Purple Biotech Backtesting, Purple Biotech Valuation, Purple Biotech Correlation, Purple Biotech Hype Analysis, Purple Biotech Volatility, Purple Biotech History as well as Purple Biotech Performance.
For information on how to trade Purple Stock refer to our How to Trade Purple Stock guide.
  
Please specify Purple Biotech's target price for which you would like Purple Biotech odds to be computed.

Purple Biotech Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Purple Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Purple Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Purple Biotech generated a negative expected return over the last 90 days
Purple Biotech has high historical volatility and very poor performance
Purple Biotech has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 1000 K. Net Loss for the year was (5.85 M) with profit before overhead, payroll, taxes, and interest of 1000 K.
Purple Biotech has accumulated about 63.01 M in cash with (5.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.4.

Purple Biotech Technical Analysis

Purple Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. Purple Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Purple Biotech. In general, you should focus on analyzing Purple Stock price patterns and their correlations with different microeconomic environments and drivers.

Purple Biotech Predictive Forecast Models

Purple Biotech's time-series forecasting models is one of many Purple Biotech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Purple Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Purple Biotech

Checking the ongoing alerts about Purple Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Purple Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Purple Biotech generated a negative expected return over the last 90 days
Purple Biotech has high historical volatility and very poor performance
Purple Biotech has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 1000 K. Net Loss for the year was (5.85 M) with profit before overhead, payroll, taxes, and interest of 1000 K.
Purple Biotech has accumulated about 63.01 M in cash with (5.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.4.

Additional Information and Resources on Investing in Purple Stock

When determining whether Purple Biotech is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Purple Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Purple Biotech Stock. Highlighted below are key reports to facilitate an investment decision about Purple Biotech Stock:
Check out Purple Biotech Backtesting, Purple Biotech Valuation, Purple Biotech Correlation, Purple Biotech Hype Analysis, Purple Biotech Volatility, Purple Biotech History as well as Purple Biotech Performance.
For information on how to trade Purple Stock refer to our How to Trade Purple Stock guide.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Please note, there is a significant difference between Purple Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Purple Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Purple Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.